Indonesia approves emergency use of China's Sinopharm Covid-19 vaccine


file7fkrbft0h5jia3on4g8

JAKARTA, April 30 (Xinhua): Indonesia's food and drug authority BPOM has issued an emergency use authorisation (EUA) for the Covid-19 vaccine produced by Chinese pharmaceutical company Sinopharm, an official source said on Friday.

Chief of BPOM Penny Lukito made the announcement, saying the issuance of the EUA was based on the third phase of clinical trials in the United Arab Emirates and other countries.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

China , Sinopharm , Sinovac , PT Bio Farma , AstraZeneca

   

Next In Aseanplus News

Japan launches fifth round of Fukushima treated water discharge
Olympics-Games' broadcaster embracing AI but remains wary of deepfakes
Malaysia closely monitoring situation in West Asia, reiterates call for all parties to exercise restraint
Four dead in UAE, Dubai airport still disrupted after storm
Olympics-McKeown breaks Australian all-comers record in 50 metres backstroke
Asean News Headlines at 10pm on Friday (April 19, 2024)
Drunk driving, crashing into police barricade lands Thai minister’s son in jail for four months
Seven people killed in Jakarta's Mampang Prabatan blaze
World No.1 and crowd favourite Viktor Axelsen headlines list of big guns vying for Singapore Badminton Open
Actress Shu Qi gets lavish surprise birthday bash from husband Stephen Fung

Others Also Read